Clinical Trials Logo

Clinical Trial Summary

This trial studies how well a mobile smoking cessation intervention works in enhancing cancer outreach in low-income adult smokers. Mobile smoking cessation intervention may help smokers quit or cut back on smoking, and help increase the range of cancer prevention services provided to low-income adult smokers.


Clinical Trial Description

PRIMARY OBJECTIVES: I. Compare the efficacy of three smoking cessation interventions targeting community based low-income uninsured and underinsured individuals in a group-randomized trial. II. Evaluate the role of quit motivation, nicotine withdrawal, risk perception, self-efficacy, social support, and negative affect as potential mediators of smoking abstinence. III. Compare the cost-effectiveness of the three treatment conditions. OUTLINE: Participants are randomized to 1 of 3 groups. GROUP I (STANDARD CARE): Participants undergo standard of care smoking cessation intervention consisting of brief advice to quit smoking, nicotine replacement therapy (NRT), and self-help written materials. GROUP II (ENHANCED CARE): Participants undergo standard of care smoking cessation intervention as in Group I and attend a health feedback counseling session at baseline. Participants also receive access to a smoking cessation hotline telephone number and supportive text messages daily for 12 weeks. GROUP III (INTENSIVE CARE): Participants undergo standard of care smoking cessation intervention as in Group I and attend a health feedback counseling session at baseline. Participants also receive access to a smoking cessation hotline telephone number, supportive text messages daily for 12 weeks, and a smoking cessation telephone call over 15 minutes weekly for 12 weeks. After completion of study, participants are followed up at 3, 6, and 12 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00948129
Study type Interventional
Source M.D. Anderson Cancer Center
Contact
Status Completed
Phase N/A
Start date August 10, 2009
Completion date February 10, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03691350 - Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs Early Phase 1
Completed NCT01967082 - APPSPIRE App in Preventing Students From Smoking N/A
Recruiting NCT03865472 - rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers N/A
Active, not recruiting NCT02271919 - Varenicline and Combined NRT for Smoking Cessation Phase 4
Withdrawn NCT03668769 - Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking N/A
Completed NCT02575885 - Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers N/A
Completed NCT04060446 - Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers
Completed NCT00941395 - Enhanced Smoking Cessation for University Students N/A
Recruiting NCT03199651 - Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer N/A
Recruiting NCT03824535 - 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules Phase 2
Completed NCT00468234 - Validation of Biomarkers of Exposure and Host Response N/A
Completed NCT00850954 - Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households N/A
Active, not recruiting NCT02697227 - Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation N/A
Completed NCT03669120 - Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking N/A